Johnson & Johnson (NYSE:JNJ)

161.25
Delayed Data
As of Apr 09
 -1.72 / -1.06%
Today’s Change
133.65
Today|||52-Week Range
173.65
+2.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$424.5B

Company Description

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Contact Information

Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick New Jersey 08933
P:(732) 524-0400
Investor Relations:
(732) 524-2955

Employees

Shareholders

Other institutional35.36%
Mutual fund holders34.33%
Individual stakeholders0.20%

Top Executives

Alex GorskyChairman & Chief Executive Officer
Joseph J. WolkChief Financial Officer & Executive Vice President
Paulus StoffelsChief Scientific Officer
James D. SwansonGlobal Chief Information Officer & Executive VP
Michael H. UllmannExecutive Vice President & General Counsel